M10.29
Drug-induced gout, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced gout, classified under ICD-10 code M10.29, is a form of gout that results from the use of certain medications. Unlike primary gout, which develops due to genetic factors or metabolic issues, drug-induced gout occurs when specific drugs interfere with the body's ability to eliminate uric acid, leading to the formation of uric acid crystals in various joints and tissues. This condition can affect multiple sites at once, causing widespread discomfort and inflammation.
Causes & Symptoms
Clinical Causes: Use of certain diuretics, especially thiazide and loop diuretics Use of aspirin in low doses Medications for tuberculosis, such as pyrazinamide Cyclosporine and other immunosuppressants Levodopa, used in Parkinson’s disease management Chemotherapy agents that increase uric acid levels Prolonged use of medications that impair kidney function Rapid reduction in body weight from dieting or starvation
Key Symptoms: Sudden and intense joint pain, often starting in the big toe Swelling in affected joints Redness and warmth around joints Joint tenderness and stiffness Multiple joints may be affected simultaneously, including ankles, knees, wrists, and elbows Formation of tophi (urate crystal deposits) in soft tissues in chronic cases Fever and malaise in some instances
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and laboratory tests. Key steps include: - Reviewing medication history to identify possible links to drug use - Blood tests to measure uric acid levels - Joint fluid analysis through aspiration, where fluid from the affected joint is examined under a microscope for uric acid crystals - Imaging studies like ultrasound or X-rays to detect tophi and joint damage While elevated uric acid levels support the diagnosis, they are not solely conclusive, as some individuals may have normal levels during an attack.
Treatment Protocols: Managing drug-induced gout involves several strategies aimed at relieving symptoms and preventing further attacks: - Discontinuing or adjusting the offending medication under medical supervision - Use of anti-inflammatory medications such as NSAIDs (e.g., ibuprofen, naproxen) - Colchicine to reduce inflammation during acute attacks - Corticosteroids for patients unable to tolerate NSAIDs or colchicine - Urate-lowering therapies like allopurinol or febuxostat, particularly if persistent hyperuricemia is present - Lifestyle modifications including adequate hydration, dietary adjustments to reduce purine intake, and weight management - Monitoring uric acid levels regularly to assess treatment effectiveness and adjust as necessary
Clinical Advice & FAQs
Billing Guidance
Is M10.29 a billable ICD-10 code?
Yes, M10.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.29?
Clinical documentation must specify the nature of Drug-induced gout, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference